Ketamine treatment for buprenorphine-precipitated opioid withdrawal: a case report
Ketamine may be an effective adjunctive agent in managing opioid withdrawal. Usually restricted to the intensive care unit and emergency department, this case report highlights both the potential and risks of IV ketamine on the general hospital floors. Further research is needed to better understand the safety of using ketamine to manage opioid withdrawal.
Authors
- Joji Suzuki (ORCID: https://orcid.org/0000-0001-5659-6147)
- Lisa Vercollone (ORCID: https://orcid.org/0009-0008-9226-9379)
- Ezioma Gbujie
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
Publication Details
- Journal
- Frontiers in Psychiatry
- Published
- 2025-06-20
- DOI
- https://doi.org/10.3389/fpsyt.2025.1586945
- Citations
- 2
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.76
Funders
- National Institutes of Health